Editas Medicine is a biotechnology company at the forefront of gene editing, utilizing CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) technologies to develop transformative therapies for serious diseases. The mission centers on translating the potential of these cutting-edge genetic tools into durable precision medicines that address significant unmet medical needs worldwide. Editas prioritizes scientific innovation and collaboration, fostering a culture of inclusivity, diversity, and belonging to empower its employees. The organization is committed to creating a healthier and more equitable future through its groundbreaking work, engaging professionals who are driven to make a meaningful impact in the field of healthcare. By joining Editas, individuals become part of a dedicated team that values their contributions and strives collectively to push the boundaries of what is possible in medicine.